| 000 | 01858 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516131727.0 | ||
| 264 | 0 | _c20130815 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1600-6143 | ||
| 024 | 7 |
_a10.1111/ajt.12061 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarbas, A S | |
| 245 | 0 | 0 |
_aPosterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation. _h[electronic resource] |
| 260 |
_bAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons _cMar 2013 |
||
| 300 |
_a808-10 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft Rejection _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aLiver Diseases _xsurgery |
| 650 | 0 | 4 |
_aLiver Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPosterior Leukoencephalopathy Syndrome _xchemically induced |
| 650 | 0 | 4 |
_aPostoperative Complications _xprevention & control |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aSirolimus _xadverse effects |
| 650 | 0 | 4 |
_aTacrolimus _xadverse effects |
| 700 | 1 | _aRege, A S | |
| 700 | 1 | _aCastleberry, A W | |
| 700 | 1 | _aGommer, J | |
| 700 | 1 | _aEllis, M J | |
| 700 | 1 | _aBrennan, T V | |
| 700 | 1 | _aCollins, B H | |
| 700 | 1 | _aMartin, A E | |
| 700 | 1 | _aRavindra, K V | |
| 700 | 1 | _aVikraman, D S | |
| 700 | 1 | _aSudan, D L | |
| 773 | 0 |
_tAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons _gvol. 13 _gno. 3 _gp. 808-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ajt.12061 _zAvailable from publisher's website |
| 999 |
_c22430785 _d22430785 |
||